MDS Virtual Congress 2021 Archives - Page 5 of 132

Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)
Technology use in Parkinson’s disease and parkinsonism: a multicenter survey in real-life Healthy East Lombardy Parkinson (HELP-)network

A. Pilotto, S. Nocivelli, D. Alimenti, J. Melgari, M. Bianchi, V. de Giuli, A. Magherini, M. Rizzeti, F. Pisano, T. Di Monda, M. Gennuso, S. Gipponi, E. Cottini, A. Imarisio, S. Masciocchi, B. Bagni, E. Magni, M. Sessa, M. Turla, B. Ferraro, P. Trippa, A. Prelle, A. Ciccone, A. Padovani (Brescia, Italy)
Technology-based adaptation of a natural history study of Parkinson disease during the COVID-19 pandemic

S. Jensen-Roberts, E. Waddell, T. Myers, M. Pawlik, J. Soto, A. Sarkar, M. Coffey, E. Stevenson, R. Wilson, E. Dorsey, K. Lizarraga, C. Tarolli, R. Schneider, J. Adams (Rochester, USA)
Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study

D. Dos Santos, D. Freire Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)
Tele-yoga for individuals with cervical dystonia: A pilot study

A. James-Palmer, J. Daneault (Newark, USA)
TELEMONITORING OF THE ORAL HEALTH OF PARKINSONIANS DURING THE NEW CORONAVIRUS PANDEMIC

C. da Silva, J. de Oliveira, N. Filho, T. da Silva, V. Marques, G. Monteiro, R. Tavares, M. Borges Andrade, A. Sobral, C. Accioly Lins (Recife, Brazil)
Telemonitoring physical exercise program during COVID-19 pandemic for individuals with Parkinson’s disease: adherence rate, barriers to attend, safety and overall experience.

C. Torriani-Pasin, V. Domingues, T. Freitas, T. Silva, M. Caldeira, R. Júnior, A. Lara, B. Araujo, G. Palma, M. Makhoul, L. Mochizuki (São Paulo, Brazil)
Telephone Visit Efficacy for Parkinson’s Disease During the COVID-19 Pandemic

F. Abu Ahmad, R. Postuma (Montreal, Canada)
Terminal Choking in Parkinson’s Disease

F. Herbert, A. Ling, E. Richfield, B. Wright (Gloucester, United Kingdom)
THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)
The actual use of directional steering and shorter pulse width in selected patients undergoing deep brain stimulation

F. Zitman, A. Janssen, N. Vander Gaag, C. Hoffmann, R. Zutt, M. Contarino (The Hague, Netherlands)
The ADOPTION (eArly levoDopa with Opicapone in Parkinson’s paTients wIth motOr fluctuatioNs) study in Parkinson’s disease: design and rationale of a randomized prospective, open-label exploratory trial

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
The alien hand syndrome

A. Balan, I. Buraga (Bucharest, Romania)
The aperiodic component of cortical Local Field Potentials is affected in Parkinson’s Disease and Essential Tremor.

A. Bush, J. Zou, W. Lipski, RM. Richardson (Boston, USA)
The application of Next Generation Sequencing in the Parkinson Disease.

E C. Chebbi (Tunis, Tunisia)
The association between antipsychotic-induced akathisia and suicidality: a systematic review

A. Kalniunas, I. Chakrabarti, R. Mandalia, J. Munjiza, S. Pappa (London, United Kingdom)
The Association Between Tic Disorders and Atopy

M. Hakimi, S. Skinner, C. Maurer (Stony Brook, USA)
THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)
The association of β-amyloid with cognition and striatal dopamine in early, non-demented Parkinson’s disease

YS. Oh, SW. Yoo, CH. Lyoo, KS. Lee, JS. Kim (Seoul, Republic of Korea)
The Burst Duration in Cortical Myoclonus Patients, What is the Cut-Off?

S. vd Veen, A. vd Stouwe, J. Elting, M. Tijssen (Groningen, Netherlands)
The Cognitive Features of Idiopathic Cervical Dystonia: a cross-sectional study

H. Oliveira, S. Camargos (Belo Horzionte, Brazil)
The Commercial Genetic Testing Landscape for Parkinson’s Disease

L. Cook, J. Schulze, J. Verbrugge, C. Klein, A. Naito, R. Alcalay (Indianapolis, USA)
The comparisons between UPDRS and MDS-UPDRS in evaluating motor dysfunctions after subthalamic nucleus deep brain stimulation

TY. Yamamoto, YY. Yamanaka, SH. Hirano, TU. Uchiyama, YH. Higuchi, SK. Kuwabara (Chiba, Japan)
The complexity metric of hand tremor identifies Parkinsonian tremor and essential tremor

T. Gin, J. Zhou (St. Louis, USA)
The Concurrent Validity of the Dual-Task L-Test in Parkinson’s Disease and its Predictive Ability in Identifying Falls

C. Griffin, A. Belton, N. Kavanagh, R. Walsh, H. French (Dublin, Ireland)
The correlations of RBD severity with motor and nonmotor features in isolated RBD patients

SY. Kang, EJ. Chung, KH. Ji, MR. Kang, SJ. Kim (Hwaseong, Republic of Korea)
The course of tremor in de novo PD: 7 year longitudinal analysis

J. Pasquini, N. Pavese (Milano, Italy)
The COVID-19 Pandemic Impact on Advanced Parkinson’s Disease in the US

D. Oleske, S. Talapala, P. Kukreja, M. Facheris, R. Dorsey, S. Dey, A. Isherwood (North Chicago, USA)
The Development of a Parkinson’s Disease Biomarker Inventory Dashboard

M. Pauley, K. Merchant, S. Hutten, M. Frasier, M. Lawton, D. Dexter, M. Muller, D. Stephenson (Tucson, USA)
The dual cognitive syndrome in Parkinson’s disease: a resting-state functional connectivity study

Q. Devignes, C. Bordier, R. Viard, G. Carey, L. Defebvre, A. Leentjens, R. Lopes, K. Dujardin (Lille, France)
The early post-transplant period in Parkinson’s disease: the low intravenous dose effect.

V. Chyzhyk, V. Ponomarev, N. Aleinikava, A. Boika, M. Zafranskaya, D. Nizheharodava (Minsk, Belarus)
THE EFFECT OF A HOME BASED SENSORIMOTOR CONTROL EXERCISE PROGRAM FOR CERVICAL DYSTONIA PATIENTS UNDER TREATMENT WITH BOTULINUM TOXIN INJECTIONS: OBSERVATIONAL STUDY

J. de Pauw, D. Crosiers, S. Girma, Y. de Borger, L. Gaspard, D. Smagghe, W. de Hertogh (Wilrijk, Belgium)
The Effect of Darkness on Gait Parameters in Patients with Parkinson’s disease.

P. Anukoolwittaya, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
The effect of deep brain stimulation on impulse control related disorders in Parkinson’s disease – a retrospective review of 137 patients

H. Shepherd, S. Healy, N. Mooney, A. da Costa, M. Bonello, D. Damodaran, J. Panicker, B. Hammersley, J. Somerset, P. Eldridge, J. Osman-Farah, S. Alusi, A. Macerollo (Liverpool, United Kingdom)
The Effect of Electromyography Biofeedback on The Frequency of Clenching on Patients with Bruxism

M. Amine, S. Sawan, U. El-Dakrory (Giza, Egypt)
The effect of exercise on pain in Parkinson’s disease: a systematic review

V. Nguy, F. Pourkazemi, L. Hassett, C. Canning, J. Elliott, N. Allen (Sydney, Australia)
The effect of medical xenon on patients with advanced stages of the Parkinson’s disease with motor fluctuations

R. Bogdanov, E. Vasilchenko, A. Dobrovolsky, P. Ratmanova, D. Napalkov, V. Bogin (Moscow, Russian Federation)
The effect of Nordic Walking on respiratory function, pain and gait in Parkinson’s disease

J. Stożek, W. Falewska, S. Podsiadło (Krakow, Poland)
The Effect of Sleep Bruxism on The Sleeping Quality

M. Amine, S. Sawan, U. El-Dakrory (Giza, Egypt)
The effect of sleep positions on morning orthostatic hypotension in Multiple System Atrophy patients: A pilot study

T. Prasertpan, J. Sringean, R. Bhidayasiri (Bangkok, Thailand)
The effect of Tuina in Traditional Chinese Medicine in treatment of Parkinson’s disease (Non-motor symptoms): a pilot clinical study

FY. Chung, HY. Lai, CS. Yuen, HW. Lam, KY. Lai, SM. Chan, M. Li, KK. Chua (Hong Kong, Hong Kong)
THE EFFECT OF VITAMIN D IN PARKINSON’S DISEASE

E. Göger, G. Yüksel, G. Gürsoy (İstanbul, Turkey)
The effectiveness of home modification on gait and falling episode in Parkinson’s disease (PD) patients.

J. Sringean, S. Phumphid, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)
The effects of acute administration of VMAT2 inhibitors on extracellular levels of dopamine, norepinephrine, 5-HT and histamine in the striatum and medial prefrontal cortex

E. Adler, L. Magid, O. Even-Chen, S. Schmidt, I. Cope, J. Alexander, J. Kehr, A. Orbach (Netanya, Israel)
The Effects of Telepractice- Based LSVT-BIG Training in Patients with Parkinson’s Disease in Covid-19 pandemic: Preliminary Results

G. Kaya Aytutuldu, B. Ersoz Huseyinsinoglu, N. Karagoz Sakalli, A. Sen (İstanbul, Turkey)
The EON (Elderly patients on ONgentys) study in Parkinson’s disease: design and rationale of a prospective non-interventional trial

V. Dostal, K. Chaudhuri, P. Odin, M. Kurtis, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (Norwich, United Kingdom)
The EPSILON (Early ParkinSon wIth L-dopa/DDCi and OpicapoNe) study in early Parkinson’s disease: design and rationale of a phase III, double-blind, randomized, placebo-controlled study

J. Ferreira, W. Poewe, O. Rascol, F. Stocchi, A. Antonini, J. Moreira, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
The evaluation of the swallow tail sign in patients with parkinsonism or gait disorders

D. Kim, G. Tung, U. Akbar, J. Friedman (Providence, USA)
The experience of respiratory symptoms and the impact in daily live in patients with Parkinson’s disease: a grounded theory approach

VA. Wetering, MJ. Nijkrake, N. Koenders, PJ. Wees, BR. Bloem, JG. Kalf (Nijmegen, Netherlands)
The experiences of treatment burden in people with Parkinson’s (PwP) and their caregivers: a systematic review of qualitative studies

QY. Tan, N. Cox, S. Lim, L. Coutts, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)
The fear of progression of Parkinson’s Disease

S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)
The feasibility and efficacy of virtual visits compared to in-person visits for follow up in Parkinson´s disease: methodology for an international, multicenter trial (NCT04695353).

JH. Ahn, J. Youn, O. Ojo, N. Okubadejo, A. Shalash, A. Cardozo, Z. Aldaajani, J. Bajwa, M. Dekker, á. Bustillo, E. Eldayem, M. Shackleford, M. Spindler, Z. Mari, E. Cubo (Seoul, Republic of Korea)
The feasibility of using an internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia

M. Wadon, M. Winter, K. Peall (Cardiff, United Kingdom)
The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

R. Schade, E. Bayram (La Jolla, USA)
The Gastrointestinal Dysfunction Scale – Parkinson’s Disease (GIDS-PD): a new tool to assess gastrointestinal dysfunction in Parkinson’s Disease

M. Camacho, J. Greenland, C. Williams-Gray (Cambridge, United Kingdom)
The gender gap in Parkinson’s disease before and after Subthalamic Nucleus Deep Brain Stimulation surgery: preliminary results of a retrospective study.

A. Trinchillo, F. Vitulli, T. Somma, F. Esposito (Naples, Italy)
The Global Parkinson’s Genetics Program (GP2) – a year’s progress

C. Blauwendraat, A. Noyce, A. Reimer, B. Casey, E. Riley, B. Fiske, M. Rizig, J. Hardy, T. Foroud, K. Murphy, N. Wood, C. Wegel, A. Brice, S. Fox, P. Heutink, R. Krueger, N. Williams, T. Gasser, K. Mok, M. Sharma, K. Marek, T. Sherer, N. Mata, M. Nalls, E. Valente, H. Morris, C. Klein, A. Singleton, T. He-Global-Parkinson’S-Genetics-Program-(gp2) (Bethesda, USA)
The Global Parkinson’s Genetics Program (GP2) Underrepresented Populations Working Group

AF. Schumacher-Schuh, S-Y. Lim, O. Okunoye, S. Bandres-Ciga, P. Heutink, H. Iwaki, R. Kruger, K. Mok, A. Noyce, NU. Okubadejo, M. Rizig, R. Rajan, LK. Prashanth, M. Sharma, J. Shulman, B. Siddiqi, S. Bardien, IF. Mata, GP2. Genetics Project (Porto Alegre, Brazil)
The GlyT1 inhibitor bitopertin reduces in the 6-OHDA-lesioned rat model of Parkinson’s disease

I. Frouni, W. Kang, C. Kwan, D. Bedard, A. Hamadjida, P. Huot (Montreal, Canada)
The gut microbiome in Parkinson’s disease: longitudinal insights into disease progression and the use of device-assisted therapies.

M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)
The Hauser Diary knowledge test as a tool to improve Rater Training Programs in Parkinson’s disease clinical trials

C. Mañeru, S. Meyer (Barcelona, Spain)
The Huntington’s Disease Structured Interview of Function (HD-SIF): A remotely administered caregiver interview for later stage HD

M. Roche, R. Fuller, L. Cherneski, O. Handley, S. Capodarca, E. Neacy, S. Frank, G. Stebbins, S. Sathe, C. Sampaio (Princeton, USA)
The Impact of Back and Neck Pain in Parkinson’s Disease: The PD-PAIN Study

D. Shpiner, T. Rundek, H. Li, I. Haq, C. Luca, J. Margolesky, H. Moore, C. Singer (Miami, USA)
The Impact of DBS on Chorea- Acanthoctosis: Case Report

SN. Erdem, H. Omercikoglu, F. Bayraklı, D. Günal (Istanbul, Turkey)
The impact of fatigue and pain on functional mobility, fear of falling, and falls in Individuals with Parkinson’s disease

N. Alissa, H. Khalil, A. Al-Sharman, I. E'Leimat, M. Al-Qawasmeh, K. El-Salem (Baltimore, USA)
The impact of gender identity and gender role orientation on health-related quality of life in people with Parkinson’s disease.

I. Göttgens, S. Darweesh, B. Bloem, S. Oertelt-Prigione (Nijmegen, Netherlands)
The impact of lockdown due to the COVID-19 pandemic on Asian cervical dystonia patients treated with Botulinum toxin injections

P. Wongwan, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)
The Impact of Visual Cueing on Gait Velocity in those with Parkinson’s Disease with Freezing of Gait

M. Scavarda, K. Nagel, D. Peterson, K. Plesher, S. Moskowitz, C. Ivy, L. Denney (Phoenix, USA)
The Implications of Pyramidal Signs in Multiple System Atrophy

C. Lin, A. Viswanathan, T. Chen, P. Faust, S. Kuo (New York, USA)
The Influence of Affective Priming on the Speech Production Network in Parkinson’s Disease

J. Schill, P. Sörös, K. Simonyan, C. Thiel, K. Witt (Oldenburg, Germany)
The influence of culture on the relationship between subjective and objective assessments of dyskinesia severity.

V. Kaasinen, CG. Goetz, P. Martinez-Martin, S. Luo, GT. Stebbins (Turku, Finland)
The influence of pain on falls in newly diagnosed Parkinson’s disease

J. Naisby, B. Galna, L. Alcock, R. Lawson, R. Morris, K. Baker, L. Rochester, D. Burn, A. Yarnall (Newcastle Upon Tyne, United Kingdom)
The lack of association between UQCRC1 and Parkinson’s disease in a southwest Chinese population

N. Li, J. Li, J. Peng, L. Duan, C. Chen, R. Peng (Chengdu, China)
The loss of skeletal muscle mass in progressive supranuclear palsy

Y. Takamatsu, I. Aiba (Sapporo, Japan)
The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.

K. Lazdovska, R. Valante (Riga, Latvia)
The mitochondrial targeted drug SBT-272 attenuates dopaminergic neuron loss, alpha-synuclein burden and neuroinflammation in a mouse model of Parkinson’s Disease

S. Bido, J. Kūka, M. Makrecka-Kuka, G. Zheng, D. Keefe, V. Broccoli (Milan, Italy)
The MJFF Global Genetic Parkinson’s Disease Research Resource

EJ. Vollstedt, JO. Aasly, B. Al Mubarak, R. Alcalay, V. Alvarez, I. Amorin, G. Annesi, D. Arkadir, M. Barkhuizen, D. Berg, V. Bonifati, A. Boon, L. Brighina, K. Brockmann, A. Carmine Belin, J. Carr, J. Clarimon, M. Cornejo-Olivas, JC. Corvol, D. Crosiers, J. Damasio, P. Das, P. Carvalho Aguiar, A. de Rosa, J. Dorszewska, S. Ertan, R. Ferese, J. Ferreira, E. Gatto, N. Giladi, H. Hanagasi, N. Hattori, F. Hentati, S. Illarioshkin, J. Jankovic, P. Klivenyi, V. Kostic, D. Koziorowski, A. Lang, SY. Lim, CH. Lin, K. Lohmann, M. Martikainen, G. Mellick, M. Merello, P. Mir, M. Pimentel, T. Pulkes, A. Puschmann, E. Sammler, M. Skaalum Petersen, M. Skorvanek, M. Spitz, L. Stefanis, O. Suchowersky, V. Tumas, EM. Valente, B. de Warrenburg, C. Williams-Gray, R. Wu, B. Zhang, A. Zimprich, C. Klein (Luebeck, Germany)
The modification of iron accumulation in nigrosome by levodopa treatment in early Parkinson’s disease

MD. Wang, HC. Wang, HX. Wang, J. Wang, SJ. Lu, RL. Ge, JB. Chen (Binzhou, China)
The neural correlates of dynamic balance control in Parkinson’s disease and freezing of gait

B. Dijkstra, M. Gilat, N. D'Cruz, A. Nieuwboer (Leuven, Belgium)
The Neuropsychiatric Inventory:Assessment Of Neuropsychiatric Symptoms In Parkinson’s Disease

GG. Uygun, GA. Yuksel, S. Kose (Istanbul, Turkey)
The OASIS (OpicApone in Sleep dISorder) study in Parkinson’s disease: design and rationale of an open-label, single-arm, pilot trial

R. Costa, C. Trenkwalder, J. Ferreira, D. Magalhães, J. Rocha, P. Soares-da-Silva (Coronado, Portugal)
The OCEAN (OpiCapone Effect on motor fluctuations and associated pAiN) study in Parkinson’s disease: design and rationale of a randomized double-blind placebo-controlled trial

K. Chaudhuri, P. Odin, J. Ferreira, A. Antonini, O. Rascol, M. Kurtis, A. Storch, K. Bannister, R. Costa, D. Magalhães, J. Rocha, P. Soares-da-Silva (London, United Kingdom)
The online MDS educational resources helped young neurologists maintain their training during the Covid-19 pandemic

S. El-Jaafary, M. Fabbri, T. de Lariestra, M. Matarazzo, B. Bergmans, M. Carecchio, R. Rajan, N. Vijiaratnam, H. Tibar, B. Bloem (Cairo, Egypt)
The pandemic stress impact on disease progression in COVID-19 seronegative patients with idiopathic Parkinson’s Disease.

M. Hansen, T. Marques, C. Pauly, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N J. Diederich (Strassen, Luxembourg)
The PD-1102 trial in advanced Parkinson’s disease: safety and clinical outcomes from a 3-year phase 1b study of AADC gene therapy administered via a posterior approach

S. Factor, R. Gross, A. van Laar, C. Christine, P. Larson, S. Kostyk, R. Lonser, E. Fine, O. Kwhaja, C. Li, A. Meier, G. Liang, E. Roberts, R. Richardson (Atlanta, USA)
The potential impact of physical activity to increase serum a-klotho levels in people with Parkinson’s disease

M. Al-Wardat (Aqaba, Jordan)
The potential of GBA1 knock-out medaka as a model animal in the search for therapeutic compounds for GBA1-related α-synucleinopathy

E. Nakanishi, M. Sawamura, Y. Taruno, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)
The prevalence and types of postural deformities in Thai patients with Parkinson’s disease: A single-center study

M. Vichutavate, P. Srivanitchapoom (Bangkok, Thailand)
The prevalence of sarcopenia in Parkinson’s disease and related disorders

A. Hart, F. Barker, A. Sayer, A. Granic, A. Yarnall (Newcastle Upon Tyne, United Kingdom)
The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)
The Prodromal PD study – multiple biomarkers for early diagnosis?

P. de Roos, D. Nyholm, M. Ingelsson (Uppsala, Sweden)
The Relationship Between Leptin Levels and Cognitive Status and Disease Stages in Patients with Alzheimer’s Disease

İ. Tuncer, G. Yuksel, H. Ti̇reli̇ (Kars, Turkey)
The responsiveness of arm swing to dopaminergic medication in Parkinson’s disease depends on task complexity

E. Warmerdam, R. Romijnders, C. Hansen, M. Elshehabi, M. Zimmermann, F. Metzger, A. von Thaler, D. Berg, G. Schmidt, W. Maetzler (Kiel, Germany)
The retrograde procedural memory in people with Parkinson’s disease with or without freezing of gait – a cross-sectional study.

L. Pauly, A. Rauschenberger, C. Pauly, M. Hansen, L. Pavelka, A. Hanff, V. Schröder, A. Leist, R. Krüger (Esch-Sur-Alzette, Luxembourg)
The Role Imposed by The High-Mobility Group Box 1 (HMGB1) Protein in MPTP-Induced Zebrafish Model of Parkinson’s Disease

K. Razali, WMY. Mohamed, N. Othman, MHM. Nasir, AA. Doolanea, J. Kumar (Kuantan, Malaysia)
The role of amylin in Parkinson´s disease neurodegenerative process

R. Bugallo, I. Martínez-Valbuena, I. Marcilla, MC. Caballero, A. Vilas-Zornoza, E. Guruceaga, JA. Sánchez-Arias, S. Ursua, A. Pérez-Mediavilla, MR. Luquin (Pamplona, Spain)
The role of community engagement and involvement in Parkinson’s disease research: a case study from Africa

N. Fothergill-Misbah, O. Thomas, H. Mwithiga, R. Walker (Newcastle Upon Tyne, United Kingdom)
The role of genetics in patient selection and outcomes of deep brain stimulation in Parkinson’s disease

K. Markopoulou, M. Farrer (Evanston, USA)
The role of network connectivity in shaping the progression of cortical atrophy in Parkinson’s disease

A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montreal, Canada)
The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

C. Mañeru, S. Meyer (Barcelona, Spain)
The satisfaction with life and treatment scale (SLTS-7) in patients with Parkinson’s disease

A. Sauerbier, P. Bachon, L. Ambrosio, P. Leohrer, A. Rizos, S. Jost, A. Gronostay, A. Konitsioti, M. Barbe, G. Fink, K. Ashkan, C. Nimsky, V. Visser-Vandewalle, K. Ray Chaudhuri, L. Timmermann, P. Martinez-Martin, H. Dafsari (Köln, Germany)
THE SEVERITY OF MOTOR SYMPTOMS IS A RISK FACTOR FOR SEBORRHEIC DERMATITIS IN PARKINSON’S DISEASE PATIENTS

I. Kuric, T. Gilman Kuric, Z. Popovic, J. Kragujevic, T. Mirosevic Zubonja, I. Rajkovaca, S. Matosa, S. Tomic ()
The sleep quality and its related factors of essential tremor patients

JX. Peng, NN. Li, JY. Li, LR. Duan, CL. Chen, R. Peng (Chengdu, China)
The study of genetic factors in motor levodopa-induced complications development in Russian patients with Parkinson’s disease

G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, G. Tayupova, S. Umutbaev, A. Baitimerov, R. Magzhanov (Ufa, Russian Federation)
THE THERAPEUTIC EFFECT OF Bacopa monnieri (WATERHYSSOP) IN TREATING PARKINSON’S DISEASE

N. Nizam, M. Ramli (Shah Alam, Malaysia)
The Transcriptome from Multiple Regions of the MPTP-induced Parkinson’s disease Mouse Brain after exercise

T. Tong, Z. Zhang, Z. Zhang, H. Hu, L. Li, J. Jin (Shanghai, China)
The Use Of Bioness L300 Go Results In Functional Gait Improvement In Patients With Parkinson’s Plus Syndromes.

R. Lovell (Altadena, USA)
The use of mHealth technology to assess gait parameters of individuals with Parkinson Disease: literature review

T. de Lima, V. Domingues, T. de Freitas, C. Pasin (São Paulo, Brazil)
The volume of STN tissue activated by DBS and the strength of its structural connectivity with SMA predicts the effects of STN-DBS on response inhibition

G. Meyer, M. Albares, S. Thobois, E. Broussolle, G. Polo, P. Baraduc, B. Ballanger, ML. Welter, B. Lau, P. Boulinguez (Bron, France)
Theory of mind in patients with cerebellar neurodegenerative disorders

O. Tamas, A. Kacar, E. Stefanova, B. Salak Djokic, A. Milovanovic, D. Stanisavljevic, M. Kostic, N. Dragasevic Miskovic (Belgrade, Serbia)
Therapy to Reduce dementia risk In Parkinson’s disease (TRIP): Proof-of-concept trial

D. Pourzinal, A. Bakker, G. Byrne, K. Mcmahon, J. O'Sullivan, R. Adam, A. Lehn, D. Copland, J. Yang, G. Pontone, T. Au, R. Littleford, M. Chatfield, Z. Mari, N. Dissanayaka (Herston, Australia)
TICS WITH FITS

S. Paneyala (Mysore, India)
Time from Referral to DBS: A Single-Centre Canadian Study

K. Yen, S. Poonja, J. Miyasaki, T. Sankar, A. Shetty, F. Ba (Edmonton, Canada)
Time to diagnosis of clinically established Parkinson’s disease or atypical parkinsonism: is a 5-year follow-up period necessary?

M. Rossi, S. Perez-Lloret, M. Merello (Buenos Aires, Argentina)
Tinospora Cordifolia protects against Rotenone induced degeneration of dopaminergic neurons in mouse model of Parkinson’s disease

S. Singh, H. Birla (Varanasi, India)
Tissue-engineered nigrostriatal pathway to rebuild dopaminergic axons in Parkinson’s disease based on clinical design criteria

W. Gordián Vélez, D. Chouhan, H I. Chen, J. Duda, D K. Cullen (Philadelphia, USA)
TNF-α Mediated Neuroinflammation Associated with UPRmt in Kaolin Induced Hydrocephalus Mouse Model

J. Zhu, M. Lee, Y. Jang, Y. Lee, E. Namgung, W. Chung, C. Seo, E. Oh, J. Heo (Daejeon, Republic of Korea)
To Prescribe or Not to Prescribe: The impact of Parkinson’s nurse prescribers

A. Hand, K. Mcewan, A. Clarke, K. Brittain, A. Bate, S. Dalkin, S. Mccarthy, R. Bradford, C. Allen, K. Mcdonald (Newcastle Upon Tyne, United Kingdom)
Total cerebral small vessel score associated with Hoehn and Yahr stages in Parkinson’s disease

X. Ma, W. Su, H. Chen (Beijing, China)
Tourette Syndrome and Driving

K. Makhoul, J. Jankovic (Houston, USA)
Towards a better understanding of social work practice in Parkinson’s disease care

J. Shurer, T. Guan, L. Zerden, N. Browner, L. Kreitzer, E. Book (Chapel Hill, USA)
Towards an automated rating of the MDS-UPDRS motor scores.

S. Marchal, G. Garraux, S. Branders, G. Bernard, C. Billocq, A. Pereira (Mont-Saint-Guibert, Belgium)
Tractography Analysis of the Pedunculopontine Nucleus Correlates with Gait Impairment in Parkinson’s Disease

S. Joza, R. Camicioli, F. Ba (Edmonton, Canada)
Transcranial direct current stimulation-related changes in postural responses to perturbations are not influenced by baseline clinical characteristics in Parkinson’s disease.

V. Beretta, R. Vitório, D. Orcioli-Silva, N. Conceição, P. Nóbrega-Sousa, M. Pereira, L. Gobbi (Rio Claro, Brazil)
Transcranial Magnetic Stimulation in Parkinsonism. Tremor and Biomechanics Evaluation

D. Labunskiy, S. Kiryukhina, A. Hamed, N. Dzhalolitdinova, S. Abdulsahib (Saransk, Russian Federation)
Translation and validation of two Parkinson’s disease specific burden questionnaires from German into French.

S. Bayen, J. Heutte, J-C. Vanderbecken, C. Moreau, L. Defebvre, W. Messaadi, D. Devos, N. Messaadi (Lille, France)
Treadmill Training (TT) and TT plus virtual reality (TT+VR) act differently on obstacle crossing performance in subjects with PD

C. Ponte, M. Putzolu, A. Botta, C. Cosentino, A. Mirelman, JM. Hausdorff, L. Avanzino, E. Pelosin (Genova, Italy)
Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals

S. Isaacson, D. Charles, C. Comella, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, R. Hauser (Boca Raton, USA)
Treatment with magnetic resonance guided focused ultrasound (MRgFUS) thalamotomy in patients with hands tremor and dystonia. A series of three cases.

L. Armengou Garcia, I. Avilés Olmos, MA. Gorospe Osinalde, M. Fernández Martínez, A. Arcadi, A. Martin Bastida, P. Manrique Lara, C. Toledano Illán, R. Villino Boquete, F. Abedrabbo Lombeyda, L. González Quarante, J. Guridi Legarra, MC. Rodriguez Oroz (Pamplona, Spain)
Tremor after organ transplantation: prevalence and characteristics

A. Stouwe, J. Elting, D. Plasmeijer, S. Bakker, G. Drost (Groningen, Netherlands)
Tremor Features Associated with Cognition in Cognitively Normal Subjects with Essential Tremor

A. Peterson, S. Chapman, K. Radler, D. Iglesias-Hernandez, S. Rizer, E. Louis, S. Cosentino (New York, USA)
Tremor in dystonia is associated with increased brain activity in the cerebellum and pallidum

F. Nieuwhof, I. Toni, A. Buijink, A. van Rootselaar, C. Gallea, M. Vidailhet, B. Vande Warrenburg, R. Helmich (Nijmegen, Netherlands)
Tremor in Writer’s Cramp Patients

S. Pandey, A. Datta, N. Batra (New Delhi, India)
TREMOR-LYTIC AND PREFRONTO-CORTICAL PROPERTIES OF Nigella sativa OIL IN PHENOL-INDUCED MICE MODELS OF ESSENTIAL TREMOR

R. Folarin, O. Oyeleye, B. Surajudeen, O. Owoniyi, O. Omotosho, N. Asaye, E. Keshinro (Sagamu, Nigeria)
Trunk postural control in seated position on a prototype of unstable chair and the interference of cognitive and motor tasks in individuals with Parkinson disease

H. Araújo, A. Miri, R. Volpe, M. Oliveira, R. Silva Jr, S. Smaili (Londrina, Brazil)